Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 known ✓ | P13945 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | GABBR2 | O75899 | 5/20 | 0.41 |
| ▸ | GABBR1 | Q9UBS5 | 5/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.38 |
| ▸ | OTC | P00480 | 1/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL1831539 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNABLMCYP3A4 | |
| Phosphoric Acid SCHEMBL1832300 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNABLMCYP3A4 | |
| Phosphoric Acid SCHEMBL63996 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL27808770 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNABLMCYP3A4 | |
| Phosphoric Acid SCHEMBL18700978 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNABLMCYP3A4 | |
| Phosphoric Acid SCHEMBL5062015 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNABLMCYP3A4 | |
| Phosphoric Acid SCHEMBL29008723 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNABLMCYP3A4 | |
| Phosphoric Acid SCHEMBL27765121 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNABLMCYP3A4 | |
| Phosphoric Acid SCHEMBL5652669 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNABLMCYP3A4 | |
| Phosphoric Acid SCHEMBL27526074 | 0.96 | ALDH1A1 (0.57) | ALDH1A1TSHRLMNABLMCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023027178-A1 | METHOD FOR PRODUCING CYTIDINE-5'-DIPHOSPHATE COMPOUND | 協和発酵バイオ株式会社 | 2023-03-02 | — | — | WO | claimed |
| WO-2023026449-A1 | METHOD FOR PRODUCING CYTIDINE 5'-DIPHOSPHATE COMPOUND | 協和発酵バイオ株式会社 | 2023-03-02 | — | — | WO | claimed |
| US-8337863-B2 | Anti-sepsis conjugate vaccine | ENDOBIOLOGICS, INCORPORATED (US) | 2012-12-25 | — | — | US | claimed |
| US-20120301500-A1 | ANTI-SEPSIS CONJUGATE VACCINE | ENDOBIOLOGICS, INCORPORATED (US) | 2012-11-29 | — | — | US | claimed |
| US-8128942-B2 | Anti-sepsis conjugate vaccine | ENDOBIOLOGICS, INCORPORATED (US) | 2012-03-06 | — | — | US | claimed |
| WO-2007059115-A1 | ANTI-SEPSIS CONJUGATE VACCINE | ENDOBIOLOGICS, INCORPORATED (US) | 2007-05-24 | — | — | WO | claimed |
| US-20060073163-A1 | Anti-sepsis conjugate vaccine | ENDOBIOLOGICS, INCORPORATED. | 2006-04-06 | — | — | US | claimed |
| US-20030138448-A1 | Anti-sepsis conjugate vaccine | GUSTAFSON, GARY L. | 2003-07-24 | — | — | US | claimed |
| EP-1278548-A2 | LIPOPOLYSACCHARIDE-CONJUGATE VACCINE FOR SEPSIS TREATMENT | ENDOBIOLOGICS, INCORPORATED (US) | 2003-01-29 | — | — | EP | claimed |
| WO-2001078787-A2 | LIPOPOLYSACCHARIDE-CONJUGATE VACCINE FOR SEPSIS TREATMENT | ENDOBIOLOGICS, INCORPORATED (US) | 2001-10-25 | — | — | WO | claimed |
| CN-116249720-B | Detoxified Lipopolysaccharide (LPS), natural non-toxic LPS and its use | 赫菲斯托斯制药公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-116249720-A | Detoxified Lipopolysaccharide (LPS), natural non-toxic LPS and its use | 赫菲斯托斯制药公司 | 2023-06-09 | — | — | CN | disclosed |
| WO-2023026449-A1 | METHOD FOR PRODUCING CYTIDINE 5'-DIPHOSPHATE COMPOUND | 協和発酵バイオ株式会社 | 2023-03-02 | — | — | WO | disclosed |
| WO-2023027178-A1 | METHOD FOR PRODUCING CYTIDINE-5'-DIPHOSPHATE COMPOUND | 協和発酵バイオ株式会社 | 2023-03-02 | — | — | WO | disclosed |
| CN-105683130-B | Curing accelerator comprising ettringite and calcium silicate hydrate | 巴斯夫建筑方案股份有限公司 | 2018-03-23 | — | — | CN | disclosed |
| US-8337863-B2 | Anti-sepsis conjugate vaccine | ENDOBIOLOGICS, INCORPORATED (US) | 2012-12-25 | — | — | US | disclosed |